Terms: = Lymphoma AND FAT1, CDHF7, 2195, ME5, hFat1, CDHR8 AND Diagnosis
6 results:
1. Characteristics of Molecular Genetic Mutations and Their Correlation with Prognosis in Adolescent and Adult Patients with Acute Lymphoblastic Leukemia.
Sun X; Liu X; Li Y; Shi X; Li Y; Tan R; Jiang Y; Sui X; Ge X; Xu H; Wang X; Fang X
Oncology; 2024; 102(1):85-98. PubMed ID: 37437551
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical features and prognosis of 166 cases of MYC/BCL2 double-expression diffuse large B-cell lymphoma].
Tang SH; Tian L; Zhao W; Wang J; Ke XY
Zhonghua Xue Ye Xue Za Zhi; 2022 Sep; 43(9):771-777. PubMed ID: 36709172
[No Abstract] [Full Text] [Related]
3. Resource limited centres can deliver treatment for children with acute lymphoblastic leukaemia with risk-stratified minimal residual disease based UKALL 2003 protocol with no modification and a good outcome.
Lashkari HP; Faheem M; Sridevi Hanaganahalli B; Bhat KG; Joshi J; Kamath N; Ahlawat S; B P
Expert Rev Hematol; 2020 Oct; 13(10):1143-1151. PubMed ID: 32870048
[TBL] [Abstract] [Full Text] [Related]
4. Serum soluble VSIG4 as a surrogate marker for the diagnosis of lymphoma-associated hemophagocytic lymphohistiocytosis.
Yuan S; Wang Y; Luo H; Jiang Z; Qiao B; Jiang Y; Hu Y; Cheng Y; Chen X; Gong W; Huang Y; Zhao W; Luo D; Liu B; Su H; Zhou J; Song S
Br J Haematol; 2020 Apr; 189(1):72-83. PubMed ID: 31960419
[TBL] [Abstract] [Full Text] [Related]
5. fat1 cadherin provides a novel minimal residual disease marker in acute lymphoblastic leukemia.
Ardjmand A; de Bock CE; Shahrokhi S; Lincz LF; Boyd AW; Burns GF; Thorne RF
Hematology; 2013 Nov; 18(6):315-22. PubMed ID: 23433465
[TBL] [Abstract] [Full Text] [Related]
6. The fat1 cadherin is overexpressed and an independent prognostic factor for survival in paired diagnosis-relapse samples of precursor B-cell acute lymphoblastic leukemia.
de Bock CE; Ardjmand A; Molloy TJ; Bone SM; Johnstone D; Campbell DM; Shipman KL; Yeadon TM; Holst J; Spanevello MD; Nelmes G; Catchpoole DR; Lincz LF; Boyd AW; Burns GF; Thorne RF
Leukemia; 2012 May; 26(5):918-26. PubMed ID: 22116550
[TBL] [Abstract] [Full Text] [Related]
